LANOXIN
- Product NDC
- 71610-019
- 11-digit product format
- 716100019
- Labeler code
- 71610
- Product ID
- 71610-019_1d7755ac-5480-4614-bc20-beb024ab95f2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- digoxin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA020405
- Marketing category
- NDA
- Marketing start
- 2012-09-30
- Substance
- DIGOXIN
- Active strength
- .125 mg/1
- Pharmacologic classes
- Cardiac Glycoside [EPC], Cardiac Glycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LANOXIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DIGOXIN | .125 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 73K4184T59 |
| Rxcui | 197604, 309888 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-019-60 | LANOXIN | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-019 | LANOXIN (DIGOXIN) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20190515_f6c7ca21-1c76-4838-8fb9-e1bec6001d8b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-019-60 | 71610001960 | 90 TABLET in 1 BOTTLE (71610-019-60) | 90 tablet | 2017-12-08 | 0000-00-00 | No | No | Current |